Sterling Capital Management’s Starling Oncology STLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$14.4K Buy
2,281
+1,714
+302% +$10.2K ﹤0.01% 2351
2026
Q2
$3.08K Buy
567
+49
+9% +$206 ﹤0.01% 2860
2026
Q1
$1.59K Buy
518
+128
+33% +$392 ﹤0.01% 3031
2025
Q4
$1.39K Buy
390
+245
+169% +$909 ﹤0.01% 3110
2025
Q3
$506 Buy
145
+2
+1% +$7 ﹤0.01% 3158
2025
Q2
$293 Buy
+143
New +$358 ﹤0.01% 3207

Other funds holding STLN

Sterling Capital Management's STLN Position: Q3 2026 in Review

Sterling Capital Management increased its Starling Oncology (STLN) stake by 302% in Q3 2026, buying an estimated $10.2K and bringing the position to 2,281 shares worth $14.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2351.

Sterling Capital Management first reported a position in STLN in Q2 2025 and has held it in 6 quarters since. 131 funds tracked by Wall St. Rank hold STLN as of Q3 2026.

  • Sterling Capital Management held 2,281 shares of Starling Oncology worth $14.4K as of Q3 2026.
  • Sterling Capital Management bought 1,714 Starling Oncology shares in Q3 2026, an estimated $10.2K.
  • Starling Oncology made up ﹤0.01% of Sterling Capital Management's portfolio in Q3 2026, its #2351 holding.
  • Sterling Capital Management first reported a position in Starling Oncology in Q2 2025 and has held it in 6 quarters since.
  • 131 funds tracked by Wall St. Rank held Starling Oncology as of Q3 2026.

Based on Sterling Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.